Skip to main content
. 2013 Summer;4(3):692–697.

Table 2.

Conventional echocardiographic measures of patients with beta-thalassemia major (TM) and healthy controls

Variables Patients with TM ( n  = 100) Group 2 (Controls) ( n  = 100) P -value
LVEDD (mm) 47.6±5.2 (39–59) 45.5±5.4 (36–53) <0.05
LVESD (mm) 28.1±5.2 (23–38) 25.2±3.7 (19–30) <0.05
IVS (d) (mm) 8.9±2.2 (7.7–13.1) 8.4±1.7 (4.7–11.4) Ns
IVS(s) (mm) 12.1±3.2 (6.9–16) 10.9±1.9 (8–12.9) Ns
LVPWD (d) (mm) 8.3±1.9 (7.8–12/1) 7.9±2.3 (6.5–12.8) Ns
LVPWD(s) (mm) 11.3±3.1 (7.9–13.9) 11.1±1.3 (9.8–12.9) Ns
FS (%) 40.6±6.1 (34–52) 45.8±7.3 (40–58) Ns
EF (%) 54.8±9.3 (45–68) 78.5±5.8 (69–81) <0.05
Mitral E (m/s) 1.1±0.4 (0.83–1.5) 1.01±0.21(0.9–1.6) NS
Mitral A (m/s) 0.8±0.5 (0.5–1.4) 0.7±0.8 (0.5–0.8) Ns
E/A ratio 1.4±1.01 (0.9–1.8) 1.8±0.8 (1.2–2.9) <0.05
DT (ms) 128±27 (83–179) 132±30 (91–180) Ns

NS, None Significant     LVEDD, Left ventricular end-diastolic diameter     LVESD Left ventricular end-systolic diameter IVS(s) Interventricular septum diameter in systole     IVS (d) Interventricular septum diameter in diastole     LVPWD(s) Left ventricular posterior wall diameter in systole     LVPWD (d) Left ventricular posterior wall diameter in diastole     FS Fractional shortening     EF Ejection fraction     Mitral E Peak early diastolic wave     Mitral A Peak late diastolic wave     DT E wave deceleration time